Trials / Completed
CompletedNCT00693420
Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 278 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bimatoprost 0.03% sterile solution | Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily. |
| DRUG | vehicle sterile solution | Apply one drop of study medication using single-use per eye applicator to upper eyelid margin once daily |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-10-01
- Completion
- 2007-12-01
- First posted
- 2008-06-09
- Last updated
- 2013-10-30
- Results posted
- 2009-05-12
Locations
2 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00693420. Inclusion in this directory is not an endorsement.